Results 261 to 270 of about 281,343 (303)

Adenovirus Meningoencephalitis

Pediatrics, 1978
Central nervous system manifestations in association with adenovirus infections have rarely been documented. In this report, four children, ages 4, 5, 6, and 10 years, with adenoviral meningoencephalitis are described. Adenoviruses were recovered from CSF specimens in all four patients.
openaire   +2 more sources

Adenovirus endocytosis

The Journal of Gene Medicine, 2003
AbstractPathogen entry into cells occurs by direct penetration of the plasma membrane, clathrin‐mediated endocytosis, caveolar endocytosis, pinocytosis or macropinocytosis. For a particular agent, the infectious pathways are typically restricted, reflecting a tight relationship with the host.
Meier, O, Greber, U F
openaire   +4 more sources

Waterborne Adenovirus

2008
Adenoviruses are associated with numerous disease outbreaks, particularly those involving d-cares, schools, children's camps, hospitals and other health care centers, and military settings. In addition, adenoviruses have been responsible for many recreational water outbreaks, including a great number of swimming pool outbreaks than any other waterborne
Kristina D, Mena, Charles P, Gerba
openaire   +2 more sources

Endocytosis of adenovirus and adenovirus capsid proteins

Advanced Drug Delivery Reviews, 2003
Key proteins of the icosahedral-shaped adenovirus (Ad) capsid mediate infection, and interact with cellular proteins to coordinate stepwise events of cell entry that produce successful gene transfer. Infection is mediated predominantly by the penton and fiber capsid proteins. The fiber initiates cell binding while the penton binds integrin coreceptors,
openaire   +2 more sources

Adenovirus transcription

Journal of Molecular Biology, 1976
P A, Sharp, S J, Flint
openaire   +2 more sources

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Lancet, The, 2022
Vitalina Dzutseva, Lihua Hou, Elena Rozhkova   +2 more
exaly  

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2020
Feng-Cai Zhu, Tao Jiang, Jun Zhang
exaly  

Adenovirus infections

Medicine, 2001
openaire   +1 more source

Adenovirus Fiber

1995
J, Chroboczek, R W, Ruigrok, S, Cusack
openaire   +2 more sources

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Lancet, The, 2020
Feng-Cai Zhu, Tao Jiang, Wei Wang
exaly